Thompson JA - Search Results

1

Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study.

Atkins MB, Hodi FS, Thompson JA, McDermott DF, Hwu WJ, Lawrence DP, Dawson NA, Wong DJ, Bhatia S, James M, Jain L, Robey S, Shu X, Homet Moreno B, Perini RF, Choueiri TK, Ribas A. Atkins MB, et al. Among authors: thompson ja. Clin Cancer Res. 2018 Apr 15;24(8):1805-1815. doi: 10.1158/1078-0432.CCR-17-3436. Epub 2018 Jan 22. Clin Cancer Res. 2018. PMID: 29358500 Clinical Trial.

2

Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.

Thompson JA, Shulman KL, Benyunes MC, Lindgren CG, Collins C, Lange PH, Bush WH Jr, Benz LA, Fefer A. Thompson JA, et al. J Clin Oncol. 1992 Jun;10(6):960-8. doi: 10.1200/JCO.1992.10.6.960. J Clin Oncol. 1992. PMID: 1588376 Clinical Trial.

3

Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.

Thompson JA, Kidd P, Rubin E, Fefer A. Thompson JA, et al. Blood. 1989 May 1;73(6):1440-3. Blood. 1989. PMID: 2713488 Free article.

4

Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma.

Thompson JA, Bianco JA, Benyunes MC, Neubauer MA, Slattery JT, Fefer A. Thompson JA, et al. Cancer Res. 1994 Jul 1;54(13):3436-41. Cancer Res. 1994. PMID: 8012963 Clinical Trial.

5

Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.

Thompson JA, Gold PJ, Fefer A. Thompson JA, et al. Semin Oncol. 1997 Feb;24(1 Suppl 4):S44-8. Semin Oncol. 1997. PMID: 9122734 Clinical Trial.

6

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.

Thompson JA, Gold PJ, Markowitz DR, Byrd DR, Lindgren CG, Fefer A. Thompson JA, et al. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S29-34. Cancer J Sci Am. 1997. PMID: 9457390 Clinical Trial.

7

Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2.

Gold PJ, Thompson JA, Markowitz DR, Neumann S, Fefer A. Gold PJ, et al. Among authors: thompson ja. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S85-91. Cancer J Sci Am. 1997. PMID: 9457401 Clinical Trial.

8

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

Figlin RA, Thompson JA, Bukowski RM, Vogelzang NJ, Novick AC, Lange P, Steinberg GD, Belldegrun AS. Figlin RA, et al. Among authors: thompson ja. J Clin Oncol. 1999 Aug;17(8):2521-9. doi: 10.1200/JCO.1999.17.8.2521. J Clin Oncol. 1999. PMID: 10561318 Clinical Trial.

9

Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer.

Jacobs A, Gold P, Weiden P, Aboulafia D, Rudolph R, Picozzi V, Thompson J. Jacobs A, et al. Cancer Invest. 2000;18(5):417-21. doi: 10.3109/07357900009032812. Cancer Invest. 2000. PMID: 10834025 Clinical Trial.

10

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A. Balch CM, et al. Among authors: thompson jf, thompson ja. J Clin Oncol. 2001 Aug 15;19(16):3622-34. doi: 10.1200/JCO.2001.19.16.3622. J Clin Oncol. 2001. PMID: 11504744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,070 results

Search Page